Skip to main content Back to Top
Advertisement

7/8/2016

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment

Reason for the Shortage

    • Perrigo has neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment on shortage due to manufacturing issues.
    • Sandoz had neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment on shortage due to increased demand.
    • Valeant had neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment on shortage due to manufacturing delay.

Available Products

    • Maxitrol ophthalmic ointment, Alcon Labs, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00065-0631-36
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Perrigo, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 00574-4160-35
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Sandoz, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 61314-0631-36
    • Neomycin and Polymyxin B Sulfates and Dexamethasone ophthalmic ointment, Valeant, 3.5 mg/1 gram - 10,000 unit/1 gram - 1 mg/1 gram 3.5 gram tube, 1 count, NDC 24208-0795-35

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated July 8, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 30, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins